标题
Antibiotics in the clinical pipeline in October 2019
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume 73, Issue 6, Pages 329-364
出版商
Springer Science and Business Media LLC
发表日期
2020-03-10
DOI
10.1038/s41429-020-0291-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A First-in-human Safety, Tolerability and Pharmacokinetics study of Benapenem in Healthy Chinese Volunteers
- (2019) Cai-yun Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sarecycline: First Global Approval
- (2019) Emma D. Deeks DRUGS
- Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
- (2019) Martti Vaara MOLECULES
- Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase
- (2019) Elizabeth G. Gibson et al. ACS Infectious Diseases
- Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties
- (2019) Gang Zhang et al. ACS Medicinal Chemistry Letters
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Future antibacterial strategies: from basic concepts to clinical challenges
- (2019) Vincent Cattoir et al. JOURNAL OF INFECTIOUS DISEASES
- Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?
- (2019) Itamar Megiddo et al. HEALTH ECONOMICS
- ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents
- (2019) Martina Durcik et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
- (2019) Khalid Eljaaly et al. DRUGS
- Omadacycline: A novel tetracycline derivative with oral and intravenous formulations
- (2019) Richard R Watkins et al. CLINICAL INFECTIOUS DISEASES
- Identification of metabolites of novel Anti‐MRSA fluoroquinolone WCK 771 in mouse, rat, rabbit, dog, monkey and human urine using liquid chromatography tandem mass spectrometry
- (2019) Ravindra D. Yeole et al. BIOMEDICAL CHROMATOGRAPHY
- Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model
- (2019) Tomefa E. Asempa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli
- (2019) Ronald Domalaon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A phase 1, randomized, single ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus THIOMAB™ antibody-antibiotic conjugate, in healthy volunteers
- (2019) Melicent Peck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis
- (2019) Jian Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems
- (2019) David W. Graham et al. Annals of the New York Academy of Sciences
- Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo
- (2019) Ye Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A First-In-Human Study to Assess the Safety and Pharmacokinetics of LYS228, a novel intravenous monobactam antibiotic in Healthy Volunteers
- (2019) Megan Osborn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- (2019) Shio-Shin Jean et al. DRUGS
- β-Lactamases and β-Lactamase Inhibitors in the 21st Century
- (2019) Catherine L. Tooke et al. JOURNAL OF MOLECULAR BIOLOGY
- C difficile—a rose by any other name…
- (2019) The Lancet Infectious Diseases LANCET INFECTIOUS DISEASES
- Phage therapy: Current status and perspectives
- (2019) Andrzej Górski et al. MEDICINAL RESEARCH REVIEWS
- Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics
- (2019) Ana V. Cheng et al. ACS Infectious Diseases
- Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions
- (2019) Cecilia Kållberg et al. ACS Infectious Diseases
- Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials
- (2019) Shao-Huan Lan et al. Infection and Drug Resistance
- Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects
- (2019) John O'Donnell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model
- (2019) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
- (2019) Xiaonan Zhang et al. BIOCHIMIE
- Non-traditional Antibacterial Therapeutic Options and Challenges
- (2019) Ursula Theuretzbacher et al. Cell Host & Microbe
- Bacterial Metabolism and Antibiotic Efficacy
- (2019) Jonathan M. Stokes et al. Cell Metabolism
- Eravacycline, a newly approved fluorocycline
- (2019) Young Ran Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against Staphylococcus aureus
- (2019) Rong Deng et al. mAbs
- Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?
- (2019) Travis B. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections
- (2019) Wei-Chu Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tentative epidemiologic cut-off value and resistant characteristic detection of apramycin against Escherichia coli from chickens
- (2019) Erjie Tian et al. FEMS MICROBIOLOGY LETTERS
- Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
- (2019) Angela Yen Moore et al. Future Microbiology
- Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
- (2019) Alen Krajnc et al. JOURNAL OF MEDICINAL CHEMISTRY
- Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of enmetazobactam and cefepime in human plasma
- (2019) M. Mameli et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The small-molecule antibiotics pipeline: 2014–2018
- (2019) Cara Lepore et al. NATURE REVIEWS DRUG DISCOVERY
- Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight Limits
- (2019) Fiorella Ruggiu et al. ACS Infectious Diseases
- Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection
- (2019) Ciarán P Kelly et al. CLINICAL INFECTIOUS DISEASES
- Antibacterials in the pipeline and perspectives for the near future
- (2019) Ian M Gould et al. CURRENT OPINION IN PHARMACOLOGY
- Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
- (2019) William O'Riordan et al. LANCET INFECTIOUS DISEASES
- (Inter)nationalising the antibiotic research and development pipeline
- (2019) Andrew C Singer et al. LANCET INFECTIOUS DISEASES
- The global preclinical antibacterial pipeline
- (2019) Ursula Theuretzbacher et al. NATURE REVIEWS MICROBIOLOGY
- Two for the price of one: Attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents
- (2019) Kiel Hards et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
- (2019) Pengfei She et al. Frontiers in Microbiology
- A two-part phase I study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonization of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation
- (2019) George A. Yendewa et al. Journal of Global Antimicrobial Resistance
- Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
- (2019) Bin Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
- (2019) Mike Sharland et al. LANCET INFECTIOUS DISEASES
- A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa
- (2018) Gloria Andolina et al. ACS Chemical Biology
- Thinking outside the box - novel antibacterials to tackle the resistance crisis
- (2018) Markus Lakemeyer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
- (2018) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens
- (2018) Susanne Paukner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China
- (2018) Zhaojing Zong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection Model
- (2018) Sean M. Stainton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model
- (2018) Anthony D. Kang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine: A useful antibiotic for drug-resistant tuberculosis
- (2018) Reza Mirnejad et al. BIOMEDICINE & PHARMACOTHERAPY
- Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228
- (2018) Folkert Reck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- Niclosamide, a Drug with Many (Re)purposes
- (2018) Hachemi Kadri et al. ChemMedChem
- Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
- (2018) Stephanie N Taylor et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship
- (2018) Toshiaki Aoki et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cefiderocol: a novel siderophore cephalosporin
- (2018) Justin J Choi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa
- (2018) Eric R. Ocheretyaner et al. Expert Review of Anti-Infective Therapy
- Murepavadin: a new antibiotic class in the pipeline
- (2018) Ignacio Martin-Loeches et al. Expert Review of Anti-Infective Therapy
- Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals
- (2018) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci
- (2018) Haroon Mohammad et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains
- (2018) A C Damião Gouveia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Revitalizing the drug pipeline: AntibioticDB, an open access database to aid antibacterial research and development
- (2018) L J Farrell et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery and development of new antibacterial drugs: learning from experience?
- (2018) Nicole Jackson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae
- (2018) Susanne Jacobsson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
- (2018) Krisztina M. Papp-Wallace et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lefamulin: Review of a promising novel pleuromutilin antibiotic
- (2018) Michael P. Veve et al. PHARMACOTHERAPY
- Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
- (2018) Rafael Baptista et al. Scientific Reports
- Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
- (2018) Ahmed AbdelKhalek et al. Scientific Reports
- Antibacterial Drug Discovery: Some Assembly Required
- (2018) Rubén Tommasi et al. ACS Infectious Diseases
- An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria
- (2018) David B Huang et al. Open Forum Infectious Diseases
- In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group
- (2018) Yuka Yamagishi et al. ANAEROBE
- In vitro activity of PBTZ169 against multiple Mycobacterium species
- (2018) Jin Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, Against Nontuberculous Mycobacteria
- (2018) Barbara A. Brown-Elliott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model
- (2018) Lindsay M. Avery et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae
- (2018) Johanne Blais et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae
- (2018) Charles R. Dean et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbiological Analysis From a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
- (2018) Nicole E. Scangarella-Oman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delafloxacin: A New Anti-MRSA Fluoroquinolone
- (2018) Louis D Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis
- (2018) Chen Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin
- (2018) Cheleste M. Thorpe et al. PLoS One
- β-lactam/β-lactamase inhibitor combinations: an update
- (2018) Kamaleddin H. M. E. Tehrani et al. MedChemComm
- Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice
- (2018) Anna B. Sheremet et al. Biomed Research International
- Bone and Joint Tissues Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery
- (2018) Annick Menetrey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
- (2018) Richard A. Preston et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis—an enzyme involved in peptidoglycan biosynthesis
- (2018) Alka Pawar et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Meeting the discovery challenge of drug-resistant infections: progress and focusing resources
- (2018) Gordon Dougan et al. DRUG DISCOVERY TODAY
- Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance
- (2018) Ilse Du Preez et al. DRUG METABOLISM REVIEWS
- Omadacycline: First Global Approval
- (2018) Anthony Markham et al. DRUGS
- Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?
- (2018) Despoina Koulenti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
- (2018) Mario Juhas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria
- (2018) Bei Shi Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Orally Absorbed Derivatives of the β-Lactamase Inhibitor Avibactam. Design of Novel Prodrugs of Sulfate Containing Drugs
- (2018) Eric M. Gordon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- Analysis of the clinical antibacterial and antituberculosis pipeline
- (2018) Ursula Theuretzbacher et al. LANCET INFECTIOUS DISEASES
- Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea
- (2018) Stephanie N. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Technologies to address antimicrobial resistance
- (2018) Stephen J. Baker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial
- (2017) C. Cao et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
- (2017) Matthew Sims et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
- (2017) Helio S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide
- (2017) Meredith A. Hackel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens
- (2017) L. M. Koeth et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases
- (2017) Chee Wei Ang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
- (2017) Wesley D. Kufel et al. PHARMACOTHERAPY
- Insertion of proteins and lipopolysaccharide into the bacterial outer membrane
- (2017) Istvan Botos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results
- (2017) Wanying Xu et al. PLoS One
- Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy
- (2017) Bryan J Donald et al. Drug Design Development and Therapy
- Antimicrobial resistance: The complex challenge of measurement to inform policy and the public
- (2017) Didier Wernli et al. PLOS MEDICINE
- Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
- (2017) Adam B. Shapiro et al. ACS Infectious Diseases
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- A Phase 1 Study to Assess the Pharmacokinetics of Sulopenem Etzadroxil (PF-03709270)
- (2017) Michael Dunne et al. Open Forum Infectious Diseases
- Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration–Approved Antibiotics, 2010–2015
- (2016) Dalia Deak et al. ANNALS OF INTERNAL MEDICINE
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Polymorphism inleuSConfers Reduced Susceptibility to GSK2251052 in a Clinical Isolate of Staphylococcus aureus
- (2016) Arya Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens
- (2016) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States
- (2016) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Obiltoxaximab: First Global Approval
- (2016) Sarah L. Greig DRUGS
- Role of bismuth in improvingHelicobacter pylorieradication with triple therapy
- (2016) Maria Pina Dore et al. GUT
- Ridinilazole: a novel therapy for Clostridium difficile infection
- (2016) Richard J. Vickers et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo
- (2016) Ludmila N Nesterenko et al. JOURNAL OF ANTIBIOTICS
- Antibiotics in the clinical pipeline at the end of 2015
- (2016) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Impact on toxin production and cell morphology inClostridium difficileby ridinilazole (SMT19969), a novel treatment forC. difficileinfection
- (2016) Eugénie Bassères et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections
- (2016) Zhenkun Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Alternatives to antibiotics—a pipeline portfolio review
- (2016) Lloyd Czaplewski et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae
- (2016) Hee-Soo Park et al. MOLECULES
- Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile
- (2016) Major Gooyit et al. Scientific Reports
- Polymyxin: Alternative Mechanisms of Action and Resistance
- (2016) Michael J. Trimble et al. Cold Spring Harbor Perspectives in Medicine
- Mycobacterium tuberculosis Thioredoxin Reductase Is Essential for Thiol Redox Homeostasis but Plays a Minor Role in Antioxidant Defense
- (2016) Kan Lin et al. PLoS Pathogens
- Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB
- (2016) Garrett C. Moraski et al. ACS Infectious Diseases
- Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
- (2016) Shankar Thangamani et al. Scientific Reports
- In VivoPharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model
- (2015) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities
- (2015) B. Hafkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoActivities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
- (2015) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SQ109, a New Drug Lead for Chagas Disease
- (2015) Phercyles Veiga-Santos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in Genes for the F420Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in SpontaneousIn Vitro-Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis
- (2015) Hana L. Haver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and EnhancedIn VivoEfficacy against Methicillin-Resistant Staphylococcus aureus
- (2015) Malvika Kaul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
- (2015) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle
- (2015) A. Dalhoff et al. CLINICAL MICROBIOLOGY AND INFECTION
- Auranofin efficacy against MDRStreptococcus pneumoniaeandStaphylococcus aureusinfections
- (2015) Leire Aguinagalde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
- (2015) Akihiro Morinaka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibition ofNeisseria gonorrhoeaeType II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914
- (2015) Gunther Kern et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- (2015) Sophie M. Lehar et al. NATURE
- Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
- (2015) Michael B. Harbut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Auranofin: Repurposing an Old Drug for a Golden New Age
- (2015) Christine Roder et al. Drugs in research & development
- Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV
- (2015) Hardwin O’Dowd et al. ACS Medicinal Chemistry Letters
- Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
- (2015) Chia-Wei Tsai et al. Frontiers in Microbiology
- Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
- (2015) Rajmohan Rajamuthiah et al. PLoS One
- In vitro activity of MCB3681 against Clostridium difficile strains
- (2014) Mamun-Ur Rashid et al. ANAEROBE
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoAntibacterial Activity of MRX-I, a New Oxazolidinone
- (2014) Cong-Ran Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
- (2014) Monalisa Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Rifampin and Ketoconazole on Pharmacokinetics of Morinidazole in Healthy Chinese Subjects
- (2014) Xiaoyan Pang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HighIn VitroActivity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea
- (2014) Susanne Jacobsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections
- (2014) Karen O'Dwyer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Ecological impact of MCB3837 on the normal human microbiota
- (2014) Mamun-Ur Rashid et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I
- (2014) Yanqin Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
- (2014) Mikhail F. Gordeev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
- (2014) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
- (2014) Robert S. Wallis et al. PLoS One
- A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
- (2014) Gregory S. Bisacchi et al. ACS Infectious Diseases
- Perturbation of Staphylococcus aureus Gene Expression by the Enoyl-Acyl Carrier Protein Reductase Inhibitor AFN-1252
- (2013) Joshua B. Parsons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723
- (2013) Malvika Kaul et al. BIOCHEMICAL PHARMACOLOGY
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
- (2012) F. Imperi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Improved Small-Molecule Inhibitor of FtsZ with SuperiorIn VitroPotency, Drug-Like Properties, andIn VivoEfficacy
- (2012) Neil R. Stokes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action,In VitroActivity, andIn VivoEfficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
- (2012) Nachum Kaplan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
- (2012) Teesta Dey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
- (2012) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis
- (2012) Dongfeng Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of Action of the Cell-Division Inhibitor PC190723: Modulation of FtsZ Assembly Cooperativity
- (2012) Nathaniel L. Elsen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Development of a Second-Generation Process to Antibacterial Candidate Sulopenem
- (2012) Steven J. Brenek et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Development of a Practical and Convergent Process for the Preparation of Sulopenem
- (2012) Steven J. Brenek et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
- (2012) S. M. Batt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
- (2012) J. Neres et al. Science Translational Medicine
- Are pleuromutilin antibiotics finally fit for human use?
- (2011) Rodger Novak Annals of the New York Academy of Sciences
- Susceptibility of ClinicalMycobacterium tuberculosisIsolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
- (2011) J. W. C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Agent Effective against Clostridium difficile Infection
- (2011) Sofya Dvoskin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 7-Alkyl-N2-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity
- (2011) Wei-chu Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- In vitro efficacy of bismuth thiols against biofilms formed by bacteria isolated from human chronic wounds
- (2011) J.P. Folsom et al. JOURNAL OF APPLIED MICROBIOLOGY
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
- (2011) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Concise Synthesis of a β-Lactamase Inhibitor
- (2011) Ian K. Mangion et al. ORGANIC LETTERS
- Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis
- (2011) Luiz Pedro S. de Carvalho et al. ACS Medicinal Chemistry Letters
- A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane
- (2010) M. Vaara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone
- (2010) J.-W. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties
- (2010) David J. Haydon et al. JOURNAL OF MEDICINAL CHEMISTRY
- How antibiotics kill bacteria: from targets to networks
- (2010) Michael A. Kohanski et al. NATURE REVIEWS MICROBIOLOGY
- Structure–activity studies on novel polymyxin derivatives that carry only three positive charges
- (2010) Martti Vaara et al. PEPTIDES
- Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
- (2010) N. Srinivas et al. SCIENCE
- XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
- (2009) C. Oefner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct
- (2009) Sarah Jackson-Rosario et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
- (2008) Hao Lu et al. ACCOUNTS OF CHEMICAL RESEARCH
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types
- (2008) S. S. Bhagwat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains
- (2008) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
- (2008) D. J. Haydon et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now